Antibiotic Regimen for UTI with Negative Nitrite and GC/Chlamydia Prophylaxis
For a UTI with negative nitrite requiring concurrent gonorrhea and chlamydia prophylaxis, use ceftriaxone 500 mg IM single dose PLUS doxycycline 100 mg orally twice daily for 7 days. This regimen provides comprehensive coverage for all three conditions simultaneously 1, 2.
Rationale for This Dual-Purpose Regimen
Gonorrhea and Chlamydia Coverage
- Ceftriaxone 500 mg IM is the gold standard for gonorrhea prophylaxis, achieving 99.1% cure rates for urogenital, anorectal, and pharyngeal infections 3, 4, 5.
- Doxycycline 100 mg twice daily for 7 days provides optimal chlamydia coverage and is the CDC's preferred agent when azithromycin single-dose therapy is not used 1, 6.
- Co-infection rates are extremely high (40-50% of gonorrhea patients also have chlamydia), making dual therapy essential for empiric treatment 1.
UTI Coverage
- Ceftriaxone provides excellent coverage for typical UTI pathogens including E. coli and other Enterobacterales, with sustained bactericidal levels 7.
- A negative nitrite test does not rule out UTI, as only 50% of UTI-causing organisms produce nitrite-reducing enzymes 7.
- Single-dose ceftriaxone has demonstrated 90% cure rates for uncomplicated UTIs 7.
Critical Advantages of This Single Regimen
- Eliminates the need for multiple antibiotics: One injection plus one oral medication covers all three conditions 1, 2.
- Superior pharyngeal gonorrhea coverage: Ceftriaxone is the only reliably effective treatment for pharyngeal infections, which are significantly more difficult to eradicate than urogenital infections 3, 5.
- Avoids fluoroquinolone resistance: Never use ciprofloxacin for gonorrhea prophylaxis due to widespread resistance 8, 9.
Alternative Regimen (If Ceftriaxone Unavailable)
- Cefixime 400 mg orally single dose PLUS doxycycline 100 mg twice daily for 7 days 10, 1.
- Mandatory test-of-cure at 1 week is required with cefixime due to inferior efficacy compared to ceftriaxone 1.
- Cefixime has only 97.1% cure rate for gonorrhea versus 99.1% for ceftriaxone 10.
Special Population Considerations
Pregnancy
- Use ceftriaxone 500 mg IM single dose PLUS azithromycin 1 g orally single dose 1.
- Never use doxycycline, quinolones, or tetracyclines in pregnancy 1, 6.
Severe Cephalosporin Allergy
- Azithromycin 2 g orally single dose for gonorrhea/chlamydia coverage 1.
- Add a separate UTI-specific antibiotic (nitrofurantoin or fosfomycin) as azithromycin has poor UTI coverage 10.
- Requires mandatory test-of-cure at 1 week due to lower efficacy (93% for gonorrhea) 1.
Critical Pitfalls to Avoid
- Never use azithromycin 1 g alone for gonorrhea: Only 93% efficacy, insufficient for prophylaxis 10, 3.
- Never use fluoroquinolones (ciprofloxacin) for gonorrhea: Widespread resistance makes them unreliable 8, 9.
- Never use spectinomycin if pharyngeal exposure suspected: Only 52% effectiveness for pharyngeal infections 3, 1.
- Do not assume negative nitrite excludes UTI: Many UTI pathogens don't produce nitrite 7.
Partner Management and Follow-Up
- All sexual partners from preceding 60 days require evaluation and treatment with the same dual therapy regimen 1.
- Patients should avoid sexual intercourse until therapy is completed and both patient and partners are asymptomatic 1.
- Retest approximately 3 months after treatment due to high reinfection risk for STIs 1, 9.
- Routine test-of-cure not needed for patients treated with recommended ceftriaxone-based regimens unless symptoms persist 1.
Dosing Summary
Recommended Regimen:
This single regimen efficiently addresses the UTI, provides gonorrhea prophylaxis, and treats/prevents chlamydia infection without requiring multiple antibiotic courses 1, 2.